申请人:Evestra, Inc.
公开号:US10273263B2
公开(公告)日:2019-04-30
Various prodrug compounds having the general structure: Active agent—(acid)-(linker)—SO2NR1R2 are described herein. Compounds having this general structure were shown to be more orally active than the unmodified parent molecule.
本文介绍了具有以下一般结构的各种原药化合物:本文描述了活性剂-(酸)-(连接体)-SO2NR1R2。与未修饰的母体分子相比,具有这种一般结构的化合物具有更高的口服活性。